CAMP and colorectal carcinoma: Our previous data revealed that genetic knockout of CRAMP (murine cathelicidin) led to increased tumour size and number in the azoxymethane‐induced murine model of colorectal cancer (CRC), suggesting a tumour‐suppressive role [5].